Erasca Reports Second Quarter 2025 Business Updates and Financial Results Efficient execution accelerated clinical entry of pan-RAS molecular glue ERAS-0015 and pan-KRAS inhibitor ERAS-4001 Phase 1 monotherapy data for RAS-targeting franchise expected in 2026 Robust balance sheet with cash, cash equivalents, and marketable securities of $387 million as of June 30, 2025 is expected to fund operations into H2 2028 SAN DIEGO, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commerc...
Shoals Technologies Group, Inc. Reports Financial Results for Second Quarter 2025 – Quarterly Revenue of $110.8 million, an increase of 11.7% year over year – – Gross Margin of 37.2% – – Operating Profit of $16.0 million – – Adjusted EBITDA1 of $24.5 million – – Backlog and Awarded Orders at Record Level of $671.3 million – – Provides Third Quarter and Increases Full Year 2025 Revenue Outlook – PORTLAND, Tenn., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. (“Shoals” or the “Company”) (Nasdaq: SHLS), a leading provider of electrical balance...
Shoals Technologies Group, Inc. Announces Participation in Upcoming Events for the Investor Community PORTLAND, Tenn., July 31, 2025 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. (“Shoals” or the “Company”) (Nasdaq: SHLS), a global leader in electrical balance of systems (“EBOS”) solutions for the energy transition market, announced today its participation in the following upcoming investor events: August 7, 2025: Barclays Virtual Fireside ChatShoals’ CEO, Brandon Moss, will participate in a fireside chat with covering analyst Christine Cho. Interested investors should contact thei...
AMREP Reports Fiscal 2025 Results HAVERTOWN, Pa., July 25, 2025 (GLOBE NEWSWIRE) -- AMREP Corporation (NYSE:AXR) today reported net income of $12,716,000, or $2.37 per diluted share, for its 2025 fiscal year ended April 30, 2025 compared to net income of $6,690,000, or $1.25 per diluted share, for the same period of the prior year. Revenues were $49,694,000 for fiscal 2025 and $51,369,000 for fiscal 2024. More information about the Company’s financial performance in 2025 and 2024 may be found in AMREP Corporation’s financial statements on Form 10-K which have today been filed with the Se...
Shoals Technologies Group Expands into South American Market with Alcones Solar Project in Chile with CJR Renewables PORTLAND, Tenn., July 08, 2025 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. (Shoals) (Nasdaq: SHLS), a global leader in electrical balance of system (EBOS) solutions for the energy transition market, announced the execution of a contract with CJR Renewables to deliver its innovative Big Lead Assembly (BLA) for the 110 MW Alcones project in the Marchigüe, Región del Libertador Bernardo O´Higgins (VI), Chile. CJR Renewables, a leading Engineering, Procurement, and Con...
Shoals Technologies Group, Inc. Announces Second Quarter 2025 Earnings Release Date and Conference Call PORTLAND, Tenn., July 07, 2025 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. (the “Company”) (Nasdaq: SHLS) today announced that the Company will release its second quarter 2025 results before market open on Tuesday, August 5, 2025, to be followed by a conference call at 8:00 a.m. (Eastern Time) on the same day. Interested investors and other parties can access the live webcast through the Investor Relations section of the Company's website at . An archived replay of the webcast ...
Shoals Technologies Group, Inc. Announces Battery Energy Storage Systems (“BESS”) Webinar PORTLAND, Tenn., June 30, 2025 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. (“Shoals” or the “Company”) (Nasdaq: SHLS), a global leader in electrical balance of systems (“EBOS”) solutions for the energy transition market, announced today that it has released a webinar on the subject of Battery Energy Storage Systems (“BESS”), followed by Q&A. The webinar is intended to be educational and informative. Further, it is being provided to allow customers, investors, analysts and other interested pa...
A director at Pulse Biosciences Inc sold 30,000 shares at 16.190USD and the significance rating of the trade was 61/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...
Shoals Technologies Group, Inc. Appoints Industry Veteran, Bobbie L. King, Jr., as Chief Legal Officer PORTLAND, Tenn., June 16, 2025 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. (“Shoals”), a leading provider of electrical balance of system solutions for the global energy transition market, announced today that it has further strengthened its executive team with the addition of Bobbie L. King, Jr. as Chief Legal Officer and Corporate Secretary to drive its legal strategy and support sustainable growth. Mr. King brings over 15 years of legal and leadership experience in the clean ...
n this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.